Halogenated ether compounds and methods of inducing anesthesia
AssigneeThe Regents of the University of California
InventorRobert J. Brosnan
Life of this patent
Estimating the term…
Abstract
A method of inducing anesthesia in a subject is provided. In some embodiments, the method provides administering to the subject via the respiratory system or via injection, an effective amount of a compound or a mixture of compounds selected from the group consisting of methyl-ethyl ethers, methyl-isopropyl ethers, and methyl-propyl ethers.
Claims18
A method for inducing anesthesia in a subject by potentiating GABAA receptors without inhibiting NMDA receptors, comprising administering to the subject via the respiratory system or via injection, an effective amount of ethane, 1-bromo-1,1,2-trifluoro-2-(trifluoromethoxy)- (CAS #2356-55-0), thereby inducing anesthesia in the subject by potentiating GABAA receptors without inhibiting NMDA receptors.
A method for inducing anesthesia in a subject in need thereof, the method comprising administering to the subject via the respiratory system or via injection, an effective amount of a halogenated methyl-ethyl ether selected from the group consisting of:
- Ethane, 2-bromo-1,1,1-trifluoro-2-(trifluoromethoxy)- (CAS #84011-04-1);
- Ethane, 1-bromo-1,2,2-trifluoro-1-(trifluoromethoxy)- (CAS #885275-60-5);
- Ethane, 2-bromo-1,1,2-trifluoro-1-(trifluoromethoxy)- (CAS #84011-03-0);
- and Ethane, 1-bromo-1,1,2-trifhioro-2-(trifluoromethoxy)- (CAS #2356-55-0).
Dependencies are inferred from the claim text.